Microsoft completed its acquisition of Sybari and said it will discontinue new sales of Sybari Antigen for Unix and Linux. No surprise there.

The company will continue sales of Antigen for Microsoft Exchange, Antigen for Microsoft SharePoint Portal Server and Windows SharePoint Services, Antigen for Instant Messaging, Antigen for SMTP Gateways, Sybari Enterprise Manager, Advanced Spam Manager, Advanced Spam Defense and Antigen for Domino on Windows NT.